Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.84
Sep. 13, 2024 16:00:00- Change 0.05 (2.7933%)
- Volume 10,005
- Today's Open 1.97
- Previous Close 1.79
- Today's High 1.97
- Today's Low 1.78
- 52 Week High 4.481
- 52 Week Low 1.57